首页> 外文期刊>Canadian journal of anesthesia: Journal canadien d'anesthesie >Inhibitory effect of tramadol on vasorelaxation mediated by ATP-sensitive K+ channels in rat aorta.
【24h】

Inhibitory effect of tramadol on vasorelaxation mediated by ATP-sensitive K+ channels in rat aorta.

机译:曲马多对大鼠主动脉ATP敏感性K +通道介导的血管舒张的抑制作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: Tramadol produces a conduction block similar to lidocaine by exerting a local anesthetic-like effect. The aims of this in vitro study were to determine the effects of tramadol on the vasorelaxant response induced by the adenosine triphosphate-sensitive K(+) (K(ATP)) channel opener, levcromakalim, in an endothelium-denuded rat aorta, and to determine whether this effect of tramadol is stereoselective. METHODS: The effects of tramadol (racemic, R(-) and S(+): 10(-6), 10(-5), 5 x 10(-5) M), and glibenclamide on the levcromakalim dose-response curve were assessed in aortic rings that had been pre-contracted with phenylephrine. In the rings pretreated independently with naloxone, and glibenclamide, the levcromakalim dose-response curves were generated in the presence or absence of tramadol. The effect of tramadol on the dose-response curve of diltiazem was assessed. RESULTS: Racemic, R(-) and S(+) tramadol (10(-5), 5 x 10(-5) M) attenuated (P < 0.0001) levcromakalim-induced relaxation in the ring with or without naloxone in a dose-dependent manner. The magnitude of the R(-)-tramadol-induced attenuation of vasorelaxant response induced by levcromakalim was greater (P < 0.05) than that induced by S(+)-tramadol. Glibenclamide almost abolished the levcromakalim-induced relaxation. Tramadol, 5 x 10(-5) M, did not significantly alter the diltiazem-induced relaxation. CONCLUSION: These results suggest that a supraclinical dose (10(-5) M) of tramadol [racemic, R(-) and S(+)] attenuates the vasorelaxation mediated by the K(ATP) channels in the rat aorta. The R(-) tramadol-induced attenuation of vasorelaxation induced by levcromaklim was more potent than that induced by S(+) tramadol. This attenuation is independent of opioid receptor activation.
机译:目的:曲马多通过发挥局部麻醉样作用而产生类似于利多卡因的传导阻滞。这项体外研究的目的是确定曲马多对三磷酸腺苷敏感的K(+)(K(ATP))通道开放剂levcromakalim在内皮剥除的大鼠主动脉中诱导的血管舒张反应的影响,以及确定曲马多的这种作用是否是立体选择性的。方法:曲马多(外消旋,R(-)和S(+):10(-6),10(-5),5 x 10(-5)M)和格列本脲对左cromakalim剂量反应曲线的影响在预先与去氧肾上腺素收缩的主动脉环中进行评估。在单独用纳洛酮和格列本脲预处理的环中,在存在或不存在曲马多的情况下,都会产生左cromakalim的剂量反应曲线。评估曲马多对地尔硫卓剂量反应曲线的影响。结果:无论是否使用纳洛酮,消旋,R(-)和S(+)曲马多(10(-5),5 x 10(-5)M)都会减毒(P <0.0001)左克莫卡林诱导的环松弛依赖的方式。 R(-)-曲马多诱导的左克莫卡林引起的血管舒张反应减弱的幅度大于S(+)-曲马多引起的(P <0.05)。格列本脲几乎消除了左克马卡林引起的松弛。 5 x 10(-5)M的曲马多并未显着改变地尔硫卓诱导的舒张作用。结论:这些结果表明曲马多的超临床剂量(10(-5)M)[外消旋,R(-)和S(+)]可减弱大鼠主动脉中K(ATP)通道介导的血管舒张作用。 R(-)曲马多引起的左旋克马林诱导的血管舒张减弱作用比S(+)曲马多引起的减弱。这种衰减不依赖于阿片受体的激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号